Viewing Study NCT04043195


Ignite Creation Date: 2025-12-24 @ 1:56 PM
Ignite Modification Date: 2026-01-01 @ 4:14 PM
Study NCT ID: NCT04043195
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-28
First Post: 2019-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC
Sponsor: Hatim Husain
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module